Standards Reporting Form: Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the CAP, Int Ass for the Study of Lung Cancer, and Association for Molecular Pathology - CAP US
LungCancer_CAP-IASLC-AMP_GIN Library - Standards Reporting Form -v6 0.pdf
—
PDF document,
440 kB (451426 bytes)